SCHEMBL6070403

SCHEMBL6070403

O=C(NCc1ccco1)c1cccc2[nH]c3c(c12)CCc1cn[nH]c1-3

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SHMT2 P34897 1/20 0.54
MAPK10 P53779 3/20 0.50
RIPK1 Q13546 3/20 0.50
HSP90AA1 P07900 1/20 0.48
HSP90AB1 P08238 1/20 0.48
HPGD P15428 7/20 0.46
ALDH1A1 P00352 6/20 0.44
KDM4E B2RXH2 4/20 0.44
LMNA P02545 4/20 0.44
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
HSD17B10 Q99714 2/20 0.44
MAPT P10636 2/20 0.44
AURKA O14965 1/20 0.44
TSHR P16473 1/20 0.44
RAB9A P51151 1/20 0.44
PTK2B Q14289 1/20 0.44
POLB P06746 3/20 0.43
NR4A1 P22736 1/20 0.43
CASP1 P29466 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6070749 0.85 MAPK10 (0.55) MAPK10RIPK1HSP90AA1HSP90AB1HPGD
SCHEMBL6070520 0.84 MAPK10 (0.53) MAPK10RIPK1HSP90AA1HPGDALDH1A1
SCHEMBL6071003 0.83 MAPK10 (0.57) MAPK10RIPK1HSP90AA1HPGDALDH1A1
SCHEMBL6071378 0.82 MAPK10 (0.60) MAPK10RIPK1HSP90AA1HPGDALDH1A1
SCHEMBL6070597 0.82 MAPK10 (0.55) MAPK10RIPK1HSP90AA1HPGDALDH1A1
SCHEMBL6071278 0.81 MAPK10 (0.54) MAPK10RIPK1HSP90AA1HPGDALDH1A1
SCHEMBL6071163 0.81 SHMT2 (0.53) SHMT2MAPK10RIPK1HSP90AA1HSP90AB1
SCHEMBL6071235 0.81 SHMT2 (0.53) SHMT2MAPK10RIPK1HSP90AA1HSP90AB1
SCHEMBL6071195 0.80 MAPK10 (0.53) SHMT2MAPK10RIPK1HPGDALDH1A1
SCHEMBL6071046 0.80 MAPK10 (0.58) MAPK10RIPK1HSP90AA1HPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060264493-A1 Tetracyclic pyrazole derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them PFIZER ITALIA S.R.L. (IT) 2006-11-23 US claimed
US-20060264493-A1 Tetracyclic pyrazole derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them PFIZER ITALIA S.R.L. (IT) 2006-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060264493-A1 Tetracyclic pyrazole derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them MAP3K1, MAP3K19, MAP3K20 SHMT2 1517/4885MAPK10 387/4885RIPK1 131/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.